medRxiv has had a significant impact on cancer research by facilitating the rapid exchange of information. During the COVID-19 pandemic, the platform demonstrated its value in disseminating critical data quickly, and this model has been equally beneficial for oncology. Researchers have used medRxiv to share early results from clinical trials, new diagnostic techniques, and emerging therapeutic approaches, accelerating the translation of research into clinical practice.
